Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
PLOS Global Public Health|June 18, 2025
Effect of antenatal care on birth outcomes in the Gambia: A propensity score matching analysisSantosh Gautam, Alasana Suso, Elizabeth WoodJournal of Nepal Health Research Council|February 12, 2019
Mean Platelet Volume and Platelet Count in Patients with Type 2 Diabetes Mellitus and Impaired Fasting GlucoseSushama Bhatta, Samir Singh, Santosh Gautam, et al.Future Oncology (London, England)|December 10, 2020
Clinical effectiveness outcomes and healthcare resource utilization of patients diagnosed with small-cell lung cancerJunji Lin, Santosh Gautam, Nan Hu, et al.Pain Medicine (Malden, Mass.)|July 17, 2015
Longitudinal Analysis of Opioid Analgesic Dose and Diabetes Quality of Care MeasuresSantosh Gautam, Luisa Franzini, Osama I Mikhail, et al.Journal of Comparative Effectiveness Research|May 28, 2021
Clinical and utilization outcomes associated with tumor mutational burden in a real-world pan-tumor populationSantosh Gautam, Sumesh Kachroo, Richard W DeClue, et al.Cardiovascular Diabetology|August 1, 2017
Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysisSantosh Gautam, Abiy Agiro, John Barron, et al.The Journal of Pain|December 1, 2015
Novel Measure of Opioid Dose and Costs of Care for Diabetes Mellitus: Opioid Dose and Health Care CostsSantosh Gautam, Luisa Franzini, Osama I Mikhail, et al.Journal of Managed Care & Specialty Pharmacy|January 2, 2018
Comparison of Specialty Medication Use for Common Chronic Inflammatory Diseases Among Health Exchange and Other Commercially Insured MembersXiaoxue Chen, Santosh Gautam, Alexander Ruggieri, et al.Future Oncology (London, England)|January 29, 2021
Real-world patterns on tumor mutation burden testing in a pan-tumor populationSantosh Gautam, Sumesh Kachroo, Richard W DeClue, et al.Future Oncology (London, England)|May 12, 2023
Comparison of advanced ovarian cancer patients treated with or without bevacizumab in the US Community Oncology ClinicsRichard W DeClue, Elizabeth A Szamreta, Santosh Gautam, et al.Pageof 3